KAPPE FÜR EINE INJEKTIONSVORRICHTUNG

Patent europeic · EP3801700 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3801700
Numer da la dumonda
EP18731717
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
29-05-2018
Publitgà
14-04-2021
Concedì
18-02-2026
La protecziun finescha il pli tard
28-05-2038
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
A61M 5/32 (2006.01)
Dumonda PCT
PCT/US2018/034852 29.05.2018
Publicaziun PCT
WO2019/231432 05.12.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 17-04-2026

    Represchentant inscrit

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 17.04.2026

  3. 18-02-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 18.02.2026

Partidas

Possessur

Janssen Pharmaceuticals, Inc.

1125 Trenton-Harbourton Road, Titusville, NJ 08560, US

Represchentant

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventur

MCLUSKY, James

Yorkshire EH6 4TF, GB

FOLEY, Nick

Yorkshire EH3 5PE, GB

MOWER, Jimmy

Yorkshire EH3 6RP, GB

CANNAMELA, Michael

Highlands, New Jersey 07716, US

KRULEVITCH, Peter

Pleasanton, California 94555, US

FLINT, James

Titusville, New Jersey 08560, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.